Estimating the efficacy of medical abortion

Contraception

Volumn 60, Issue 3, 1999, Pages 119-135

  Trussell, James ^a,b   Ellertson, Charlotte ^c  

^a PRINCETON UNIVERSITY   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c POPULATION COUNCIL   (Mexico)

Author keywords

Efficacy; Medical abortion

Indexed keywords

COCODAMOL; GEMEPROST; METHOTREXATE; METHYLERGOMETRINE MALEATE; MIFEPRISTONE; MISOPROSTOL; PARACETAMOL;

BLEEDING; CLINICAL PROTOCOL; CONTRACEPTION; DRUG EFFICACY; FEMALE; GYNECOLOGIC SURGERY; HUMAN; INDUCED ABORTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; LIFE TABLE; MEDICAL LITERATURE; MODEL; MUSCLE CRAMP; ORAL DRUG ADMINISTRATION; PAIN; REVIEW; STATISTICAL ANALYSIS;

EID: 0032763212     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(99)00078-5     Document Type: Article

References (61)

1. Aubény E., Peyron R., Turpin C.L., et al. Termination of early pregnancy (up to and after 63 days of amenorrhea) with mifepristone (RU 486) and increasing doses of misoprostol. Int J Fertil. 40:1995;85-91.
2. Peyron R., Aubény E., Targosz V., et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med. 328:1993;1509-1513.
3. Silvestre L., Dubois C., Renault M., Rezvani Y., Baulieu E.E., Ulmann A. Voluntary interruption of pregnancy with mifepristone (RU 486) and prostaglandin. N Engl J Med. 322:1990;645-648.
4. Urquhart D.R., Templeton A.A., Shinewi F., et al. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK multicentre study - final results. Contraception. 55:1997;1-5.
5. Winikoff B., Sivin I., Coyaji K., et al. Efficacy of the mifepristone/misoprostol regimen of medical abortion a comparative trial in China, Cuba and India . Am J Obstet Gynecol. 176:1997;431-437.
6. Winikoff B, Sivin I, Coyaji K, et al. The acceptability of medical abortion in China, Cuba and India. Int Fam Plann Perspect 1997;23:73-8,89.
7. Ngoc NTN, Winikoff B, Elul B, et al. Safety, efficacy and acceptability of medical abortion in Vietnam. Int Fam Plann Perspect 1999;25:10-4,33.
8. Carbonell J.L., Esteve I., Valazco A., et al. Misoprostol 3, 4, or 5 days after methotrexate for early abortion a randomized trial . Contraception. 56:1997;169-174.
9. Creinin M.D., Vittinghoff E., Schaff E., et al. Medical abortion with oral methotrexate and vaginal misoprostol. Obstet Gynecol. 90:1997;611-616.
10. Hausknecht R.U. Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med. 333:1995;537-540.
11. Wiebe E.R. Abortion induced with methotrexate and misoprostol a comparison of various protocols . Contraception. 55:1997;159-163.
12. Creinin M.D., Darney P.D. Methotrexate and misoprostol for early abortion. Contraception. 48:1993;339-348.
13. Blayo C. L'évolution du recours à l'avortement en France depuis 1976. Population. 3:1995;779-810.
14. Cameron S.T., Glasier A.F., Logan J., et al. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh. Br J Obstet Gynaecol. 103:1996;1222-1229.
15. Wiebe E.R. Abortion induced with methotrexate and misoprostol. Can Med Assoc J. 154:1996;165-170.
16. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect 1998;30:24-9,46.
17. Spitz I.M., Bardin C.W., Benton L., Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med. 338:1998;1241-1247.
18. Creinin M.D., Shulman T. Effect of nonsteroidal anti-inflammatory drugs on the action of misoprostol in a regimen for early abortion. Contraception. 56:1997;165-168.
19. Harper C., Winikoff B., Ellertson C., Coyaji K.J. Blood loss with mifepristone-misoprostol abortion measures from a trial in China, Cuba and India . Int J Obstet Gynecol. 63:1998;39-50.
20. Chan Y.F., Ho P.C., Ma H.K. Blood loss in termination of early pregnancy by vacuum aspiration and by combination of mifepristone and gemeprost. Contraception. 47:1993;85-95.
21. Prasad R.N.V., Choolani M., Roy A., Ratnam S.S. Blood loss in termination of early pregnancy with mifepristone and gemeprost. Aust New Zealand J Obstet Gynaecol. 35:1995;329-331.
22. Rodger M.W., Baird D.T. Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost). Contraception. 40:1989;439-447.
23. Thong K.J., Baird D.T. Induction of abortion with mifepristone and misoprostol in early pregnancy. Br J Obstet Gynaecol. 99:1992;1004-1007.
24. McKinley C., Thong K.J., Baird D.T. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod. 8:1993;1502-1505.
25. Termination of pregnancy with reduced doses of mifepristone. Br Med J. 307:1993;532-537.
26. Weeks A.D., Stewart P. The use of low dose mifepristone and vaginal misoprostol for first trimester termination of pregnancy. Br J Fam Plann. 21:1995;85-86.
27. Penney G., McKessock L., Rispin R., El-Refaey H., Templeton A. An effective, low cost regimen for early medical abortion. Br J Fam Plann. 21:1995;5-6.
28. Ashok P.W., Penney G.C., Flett G.M.M., Templeton A. An effective regimen for early abortion a report of 2000 consecutive cases . Hum Reprod. 13:1998;2962-2965.
29. Schaff E.A., Eisinger S.H., Stadalius L.S., Franks P., Gore B.Z., Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception. 59:1999;1-6.
30. El-Refaey H., Templeton A. Early induction of abortion by a combination of oral mifepristone and misoprostol administered by the vaginal route. Contraception. 49:1994;111-114.
31. El-Refaey H., Rajasekar D., Abdalla M., Calder L., Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med. 332:1995;983-987.
32. Ellertson CE, Simonds W, Winikoff B, Springer K, Bagchi D. Providing mifepristone-misoprostol medical abortion: the view from the clinic. J Am Med Wom Assn 1999;54:91-6,102.
33. Schaff E.A., Stadalius L.S., Eisinger S.H., Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract. 44:1997;353-360.
34. DeLoia J.A., Stewart-Akers A.M., Creinin M.D. Effects of methotrexate on trophoblast proliferation and local immune responses. Hum Reprod. 13:1998;1063-1069.
35. Creinin M.D., Vittinghoff E. Methotrexate and misoprostol vs misoprostol alone for early abortion. JAMA. 272:1994;1190-1195.
36. Creinin M.D., Vittinghoff E., Galbraith S., Klaisle C. A randomized trial comparing misoprostol three and seven days after methotrexate for early abortion. Am J Obstet Gynecol. 173:1995;1578-1584.
37. Creinin M.D. Medical abortion with methotrexate 75 mg intramuscularly and vaginal misoprostol. Contraception. 56:1997;367-371.
38. Schaff E.A., Eisinger S.H., Franks P., Kim S.S. Combined methotrexate and misoprostol for early induced abortion. Arch Fam Med. 4:1995;774-779.
39. Carbonell J.L.L., Varela L., Velazco A., Cabezas E., Fernández C., Sánchez C. Oral methotrexate and vaginal misoprostol for early abortion. Contraception. 57:1998;83-88.
40. Carbonell Esteve J.L., Varela L., Velazco A., Cabezas E., Tanda R., Sánchez C. Vaginal misoprostol for late first trimester abortion. Contraception. 57:1998;329-333.
41. Carbonell J.L.L., Varela L., Velazco A., Fernández C. The use of misoprostol for termination of early pregnancy. Contraception. 55:1997;165-168.
42. Carbonell J.L.L., Varela L., Velazco A., Fernández C., Sánchez C. The use of misoprostol for abortion at ≤9 weeks' gestation. Eur J Contracept Reprod Health Care. 2:1997;181-185.
43. Bugalho A., Faúndes A., Jamisse L., Usfá M., Maria E., Bique C. Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion. Contraception. 53:1996;243-246.
44. Blanchard K, Winikoff B, Ellertson C. Misoprostol used alone for the termination of early pregnancy: a review of the evidence. Contraception 1999;59:209-217.
45. Grimes D.A. Medical abortion in early pregnancy a review of the evidence . Obstet Gynecol. 89:1997;790-796.
46. Nuutila M., Toivonen J., Ylikorkala O., Halmesmäki E. A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion. Obstet Gynecol. 90:1997;896-900.
47. Ho P.C., Ngai S.W., Liu K.L., Wong G.C.Y., Lee S.W.H. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy. Obstet Gynecol. 90:1997;735-738.
48. Weeks A.D., Stewart P. The use mifepristone in combination with misoprostol for second trimester termination of pregnancy. Br J Fam Plann. 21:1995;43-44.
49. Sang G.W., Weng L.J., Shao Q.X., et al. Termination of early pregnancy by two regimens of mifepristone with misoprostol and mifepristone with PG05 - a multicentre randomized clinical trial in China. Contraception. 50:1994;501-510.
50. Baird D.T., Sukchareon N., Thong K.J. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion. Hum Reprod. 10:1995;1521-1527.
51. Ulmann A., Silvestre L., Chemama L., et al. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Acta Obstet Gynecol Scand. 71:1992;278-283.
52. Creinin M.D., Park M. Acceptability of medical abortion with methotrexate and misoprostol. Contraception. 52:1995;41-44.
53. Winikoff B., Ellertson C., Elul B., Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol results of a large multi-center trial in the United States . Arch Fam Med. 7:1998;360-366.
54. Hakim-Elahi E., Tovell H.M., Burnhill M.S. Complications of first-trimester abortion a report of 170,000 cases . Obstet Gynecol. 76:1990;129-135.
55. Winikoff B., Ellertson C., Clark S. Analysis of failure in medical abortion. Contraception. 54:1996;323-327.
56. Trussell J., Kost K. Contraceptive failure in the United States a critical review of the literature . Stud Fam Plann. 18:1987;237-283.
57. Trussell J., Grummer-Strawn L. Contraceptive failure of the ovulation method of periodic abstinence. Fam Plann Perspect. 22:1990;65-75.
58. Trussell J., Grummer-Strawn L. Further analysis of contraceptive failure of the ovulation method of periodic abstinence. Am J Obstet Gynecol. 165:1991;2054-2059.
59. Trussell J, Strickler J, Vaughan B. Contraceptive efficacy of the diaphragm, the sponge and the cervical cap. Fam Plann Perspect 1993;25:100-5,135.
60. Trussell J., Sturgen K., Strickler J., Dominik R. Comparative contraceptive efficacy of the female condom and other barrier methods. Fam Plann Perspect. 26:1994;66-72.
61. Namboodiri K, Suchindran CM. Life table techniques and their applications. New York: Academic Press, 1987.